Posts in Tag


The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has created a new tech fellowship to increase diversity in the industry. NIBIB aims to transform the understanding of disease and its prevention, detection, diagnosis, and treatment through engineering. Bringing new medical technologies to the marketplace is a long, expensive process that can be even more challenging for underrepresented entrepreneurs in biotech. Recognizing the need for more biotechnology innovators from underrepresented groups and building on its history of working with leaders in the biotech industry, NIBIB created the RADx Tech DIVE fellowship program.

Dr. Abasi Ene-Obong, the founder of 54gene, has started a new company, Syndicate Bio. The rise and fall of 54gene In 2019, Ene-Obong founded 54gene, a Nigerian health and biotech startup, to address the gap in the genomics market. At the height of the pandemic, the organization seized the opportunity to earn more money by transforming its lab into a COVID testing center. But, as Covid cases reduced and fewer people carried out tests, many of the staff 54gene recruited had to be let go. The organization was forced to

Over 70 years after Henrietta Lacks’ cervical cells were taken without her knowledge, her family finally settled with Thermo Fisher Scientific, a biotech company they say profited from them. Henrietta Lacks Lacks was a Black mother of five who died of cervical cancer in October 1951 at 31. She had learned she had cervical cancer eight months before her death when she was admitted to a racially segregated ward at John Hopkins Hospital, Baltimore.  Following a tumor biopsy, doctors saved a sample of Lacks’ cancer cells without telling her and